One Under-the-Radar Stock With 100% Upside Potential
POET Technologies (POET) is highlighted for its potential in silicon photonics, with a $18.11 price target implying 111.8% upside. The company reported Q2 2026 revenue of $569,925, up 112.29% YoY, but missed estimates. POET has $796M in cash and a $500M potential deal with Lumilens. Risks include competition, dilution, and production delays. Comparisons are made to Coherent (COHR) and Credo (CRDO).
How this was made
The 30-second read
Why it matters
The new price target may spur short‑term speculative interest, but the underlying execution risk remains high.
Market read
Analyst coverage adds modest visibility to POET but does not constitute a major market‑moving event.
What to watch
Potential competition from larger incumbents and the impact of warrant dilution on future equity value.
Background
Silicon photonics is a hot theme in AI infrastructure, with POET positioned as a pre‑revenue player seeking to capture market share.
Ticker impact
Analyst issues a new $18.11 price target and 111.8% upside estimate for POET, citing recent quarterly results and contract news.
Modest upside pressure if investors accept the target; downside risk if production delays persist.
Target is based on speculative execution assumptions; large cash war chest offsets some risk.
Market effects
Highlights growing interest in AI photonics and silicon photonics within the AI infrastructure sector.
Focus on Malaysia manufacturing may draw attention to Southeast Asian tech supply chains.
Limited; primarily relevant to niche AI optics investors.
Counterpoint
The company's pre‑revenue status and execution delays could lead to significant downside beyond the analyst's target.
Key entities
- CompanyPOET Technologies
NASDAQ‑listed AI photonics firm.
